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Cell cycle checkpoints are the surveillance mechanisms monitoring both the fi-
delity and accuracy of DNA replication and the segregation of chromosomes. By
delaying progression through the cell cycle, checkpoints provide more time for
repair before the critical phases of DNA replication and ensure the proper segre-
gation of chromosomes during mitosis. The paper provides basic information
about the molecular mechanisms operating in various cell cycle checkpoints ac-
tivated by DNA damage or disturbances in mitotic spindle assembly.
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INTRODUCTION
The cell cycle consists of DNA synthesis (S) and
mitosis (M) phases separated by gap (G) phases in
the order G1-S-G2 M. It is driven by the sequential
activation of a number of Ser/Thr protein kinases that
become active when they associate with their respec-
tive regulatory cyclin subunits. Each of these cyclin-
dependent kinases (Cdk kinases) phosphorylates and
therefore alters the proteins required for the execu-
tion of specific cell cycle events. The activities of Cdk
kinases are regulated by changes in the supply of the
cyclin subunit (proteins that exhibit the characteristic
pattern of appearance and disappearance during the
cell cycle), by inhibitory or activatory phosphorylations
of the catalytical subunit and by association with dif-
ferent inhibitory proteins (Cdk inhibitors) [1, 5]. Pro-
gression from one phase of the cell cycle to the
next can be initiated only after passage through
what are known as checkpoints (a concept intro-
duced by L. Hartwell, Nobel laureate in 2001 [7]),
where correct completion of the preceding steps is
verified. Checkpoints, therefore, may be considered
as surveillance mechanisms controlling the order and
timing of cell cycle events and ensuring that biochem-
ically independent processes are completed. A delay
in a critical cell cycle process will cause a delay in all
other events of the cell cycle progression. If the dam-
age is irreparable, checkpoint signalling activates path-
ways that lead to programmed cell death. Loss of
checkpoint integrity can allow the propagation of DNA
lesions and result in permanent genomic alterations.
Most of the information about molecular mechanisms
and proteins involved in cell cycle checkpoints has
been obtained in genetic studies of budding and fis-
sion yeasts, in which mutants defective in particular
phases of the cell cycle were produced. Nowadays
we have already discovered that an essential mecha-
nism for the maintenance of genomic integrity exhib-
its a high degree of evolutionary conservation in eu-
karyotes and that multiple mechanisms could control
the same cell cycle transition point. This enables the
checkpoint to respond to different types of stress and
apply precise control.
Two main classes of checkpoint can be distin-
guished, one connected with cellular responses to
DNA damage and the other occurring during mitosis.
DNA damage-induced checkpoints
Checkpoints activated by various types of DNA
damage may occur at the border of G1/S phases
(G1 phase checkpoint), during the S phase (intra-S
phase checkpoint, DNA replication checkpoint, genome
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integrity checkpoint), during G2 and at the border
of G2/M phases (G2 damage checkpoint, G2/M
phase checkpoint) [11]. These were originally de-
fined as regulatory pathways that control the abil-
ity of cells to arrest the cell cycle in response to
DNA damage, allowing time for repair. It is now
known that, in addition to controlling cell cycle ar-
rest, these pathways also control DNA repair path-
ways, various transcriptional programmes and te-
lomeres length as well as induce routes leading to
cell death by apoptosis.
Three major groups of proteins: sensors, transduc-
ers and effectors are known which act in concert to
translate the signal of damaged DNA into a cellular
response. As sensor proteins that recognise damaged
DNA directly or indirectly and signal the presence
of abnormalities the following are proposed:
poly(ADP-ribose) polymerase, DNA-dependent pro-
tein kinase, as well as proteins related in structure
to PCNA (Rad 9, Rad 1, Hus 1) or subunits of repli-
cation factor C (Rad 17). Among transducer pro-
teins two protein kinases, ATM and ATR, related to
the phosphoinositide 3-kinase, play the central role
in the entire DNA damage response [8]. These am-
plify the damage signal from the sensors by phos-
phorylating other kinases (e.g. checkpoint kinases
Chk1 and Chk2) and other effector proteins involved
in DNA repair, transcription regulation and cell cy-
cle control such as BRCA1, Nbs1(Nibrin), p53 and
phosphatase Cdc25.
In the regulation of the G1 checkpoint the tumour
suppressor protein p53 is the major damage effector
protein [2]. It prevents the onset of the S-phase
through transcriptional regulation of p21, a Cdk
kinases inhibitor, as well as GADD45, a protein able
to complex with PCNA, or 14-3-3, proteins that rec-
ognise and bind proteins containing phosphorylat-
ed serines. As a result, the activity of Cdk2 kinase
complexed with cyclin E, necessary for S-phase ini-
tiation, is suppressed. In this situation suppressor
protein Rb remains unphosphorylated and bound
to transcription factor E2. Moreover, the transcrip-
tion of genes coding proteins required for DNA syn-
thesis is still blocked. An elevated intracellular level
of p53 protein is observed in cells treated with ion-
ising and UV irradiation, mainly as a result of its
increased stability. Phosphorylation of p53 by ATM
on Ser15 and by ATM-activated Chk2 kinase on
Ser20 prevents its targeted degradation in protea-
some 26S. Additionally, phosphorylation by ATM
of MDM2 cellular protein, acting as ubiquitin ligase,
interferes with its ability to bind p53, which con-
tributes to the stabilisation and nuclear accumula-
tion of p53.
The S-phase checkpoint is of particular impor-
tance, since duplicaton of the genome takes place
in the S phase and repair of damaged DNA in this
phase may be the final line of defence to eliminate
DNA lesions before they are converted into inherit-
able mutations. A number of mechanisms have
been identified for the attenuation of the S-phase
in response to DNA damage. The main mechanism
includes sequential action of ATM and Chk2 kinas-
es, which leads to inhibitory phosphorylation of
Cdc25A phosphatase, responsible for Tyr15 dephos-
phorylation and therefore activation of all Cdk ki-
nases. The other is the pathway ATM-Nbs1, which
probably participates in the inactivation and sub-
sequent degradation of Cdc25C phosphatase. The
other downstream factors of this pathway, proba-
bly proteins involved in DNA replication, are yet to
be identified.
In the G2 phase checkpoint, which controls the
transition from the G2 phase to mitosis, the phos-
phatase activity of Cdc25C is of special importance,
as it activates Cdk1 kinase complexed with cyclin B
or A, indispensable for mitosis. Phosphorylation of
Cdc25C phosphatase by Chk1 kinase, activated ei-
ther by ATM or ATR, provides an effective G2/M block
upon recognition of DNA damage.
Checkpoints during mitosis
During mitosis at least two checkpoints are
present. The first is named the CHFR checkpoint, af-
ter a gene encoding a protein which possesses Fork-
head-associated and RING finger domains as well as
ubiquitin ligase activity [3]. This occurs during
prophase when CHFR protein inhibits chromatin con-
densation and therefore entry into the metaphase.
The second checkpoint is situated between the
metaphase and anaphase and is named the “spin-
dle assembly” checkpoint, mitotic checkpoint, or
spindle checkpoint [10]. It monitors the microtubule
structure and chromosome attachments to the mi-
totic spindle and delays chromosome aggregation
during the anaphase, until defects in the mitotic
spindle apparatus are corrected. Crucial constituents
of this checkpoint are the kinetochore-associated
proteins, designated as MAD2, BUBR1, BUB1 and
BUB2, which are able to form multicomponent com-
plexes. These act in concert and regulate (especially
MAD2 and BUBR1) mitotic progression by direct in-
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teraction and inhibition of the APC ubiquitin ligase
responsible for the proteolytic degradation of mul-
tiple protein substrates, such as cyclins B and A and
securin Pds1 [4]. Their proteolysis at the metaphase/
/anaphase transition, as well as disruption of the mi-
crotubules, allows sister chromatid separation and
further progression of the cell cycle.
When checkpoints fail…
The question as to whether a causal relationship
exists between checkpoint failure, genomic instabil-
ity and cancer is of special importance. It is already
well documented that genetic alterations in genes
encoding signalling molecules that act in the vari-
ous cell cycle checkpoints may lead to tumourigene-
sis. Mutations in the p53 tumour suppressor gene,
common in the majority of human cancers, cause
the inability of mutated p53 protein to precisely con-
trol the expression of genes coding some constitu-
tive cell cycle machinery components as well as
proapoptotic genes. Moreover, mutated p53 protein
cannot be phosphorylated by kinase Chk2. Inacti-
vating mutations of ATM, BRCA1/2 and Nbs1 genes
cause defects in DNA damage signalling, give rise to
some forms of chromosomal instability and increase
the risk of cancer, especially of leukaemia and lym-
phoma. The presence of mutated mitotic checkpoint
genes such as CHFR, BUBR1 and MDM2 in various
tumour cells has also been reported. It is obvious
that understanding of the molecular mechanisms of
cell cycle regulation and checkpoint abnormalities
in tumours offers an insight into potential therapeutic
strategies [6, 9, 12].
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